Jeffrey R. Currier

A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

Jeffrey R. Currier, Ellen Kuta, Lyndsay B Earhart et al. · Journal of Immunological Methods · 2002 · 323 citations

Vaccination, Vaccine Development, Mhc Class +9

The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120

Nicos Karasavvas, Erik Billings, Mangala Rao et al. · AIDS Research and Human Retroviruses · 2012 · 210 citations · Full text

Vaccination, Hiv-1 Acquisition, Antibody Responses +12

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity

Michael Joyce, Wei‐Hung Chen, Rajeshwer S. Sankhala et al. · Cell Reports · 2021 · 177 citations · Full text

CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients

Christof Geldmacher, Jeffrey R. Currier, Eva Herrmann et al. · Journal of Virology · 2006 · 159 citations · Full text

Hla Immunogenetics, Immunology, Antigen Processing +18

The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope

Mark de Souza, Silvia Ratto‐Kim, Weerawan Chuenarom et al. · The Journal of Immunology · 2012 · 139 citations · Full text

Adaptive Immune System, Immunodeficiencies, Immunology +21